Brazil Says It’s Ready and Willing to Break AIDS Drugs Patents

According to Pedro Chequer, the coordinator of Brazil’s Sexually Transmitted Disease/Aids program, the country may break patents with pharmaceutical companies and manufacture generic versions of up to a total of five brand name retroviral drugs.

“There is a concrete possibility that we will break patents under existing international agreements. And we now have the technical capacity to begin manufacturing next year. We will be able to deal with the manufacturing process all the way from the molecular level to the finished product,” he said.


However, Chequer refused to specifiy which AIDS drugs, out of the eight Brazil presently has to import, could have their patents broken.


He also did not disclose the amount of money Brazil was spending on research, but he did say that the Brazilian Development Bank (BNDES), along with laboratories in both the public and private sectors, were running studies on the country’s capabilities with the objective of eventually creating a new reality with new perspectives in the pharmaceutical area.


“What this means is that besides the seven AIDS drugs we already make generic versions of, we will expand our production capacity significantly with another three to five generic versions of other brand name drugs,” said Chequer.


The justification for breaking patents, explained Chequer, is that Brazil is forced to spend too much on imported AIDS drugs which could be made domestically in public or private labs.


He points out that around 80% of his budget (some US$ 165 million or R$ 450 million) goes to paying for the importation of only seven drugs that are used in treating AIDS.


Brazil’s Sexually Transmitted Disease/AIDS program, as part of the Brazilian public health network (SUS), supplies approximately 150,000 HIV-positive patients with 15 drugs free of charge to treat the disease and keep it under control.


Out of those 15 drugs, seven are now produced in Brazil in generic versions and the remaining eight are imported. Among the eight imported drugs is the newest in the so-called AIDS cocktail, Aazanavir, which is made in the United States by Bristol-Myers Squibb.


Agência Brasil
Translator: Allen Bennett

Tags:

You May Also Like

Brazil: EU to Eliminate Surtax to Mercosur Products

The trade negotiations now underway between Mercosur and the European Union, which are scheduled ...

Fernando Inácio Henrique Lula da Silva of Brazil

Overseas, President Lula says everything we would love him to say. He criticizes the ...

Brazil and Neighbors Have Found They Don’t Need Uncle Sam’s Consent

Over the past few years we have faced two major challenges in conceiving of ...

At Eve of Brazilian Elections Lula’s Aide Resigns Charged with Dirty Campaigning

A special advisor to Brazilian President Luiz Inácio Lula da Silva has resigned his ...

Lula Offers Brazil Expertise to Uruguay

Brazil wants to help the new Uruguayan government in the formulation of a development ...

Bye Bye, Rat Race! Hello, Brazil!

My leaving the United States for Brazil, a place I’d never been, was like ...

Senegal, the Last Leg of Brazil Lula’s African Tour

Brazilian President Luiz Inácio Lula da Silva kept official commitments today, the last day ...

Asylum to Ecuador’s Leader Is Not Political Act, Says Brazil

Brazil’s ambassador in Ecuador, Sérgio Florêncio, said Monday, April 25, that the concession of ...

Brazilian weekly magazine Isto Ë cover shows Lula

Now Come the Reforms in Brazil. Bankers Will Love Them

Despite all the exposures of rampant corruption that characterized Brazilian President Luiz Inácio Lula ...

Free Software Is Major Theme at Brazil’s World Social Forum

The debate over freedom of information is one of the principal themes of the ...

WordPress database error: [Table './brazzil3_live/wp_wfHits' is marked as crashed and last (automatic?) repair failed]
SHOW FULL COLUMNS FROM `wp_wfHits`